Rothschild Asset Management Inc. decreased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 22.4% during the first quarter, Holdings Channel reports. The firm owned 7,165 shares of the medical instruments supplier’s stock after selling 2,073 shares during the period. Rothschild Asset Management Inc.’s holdings in DENTSPLY SIRONA were worth $447,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the stock. Howard Hughes Medical Institute increased its position in shares of DENTSPLY SIRONA by 134.9% in the first quarter. Howard Hughes Medical Institute now owns 2,751 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 1,580 shares during the period. Penserra Capital Management LLC increased its position in shares of DENTSPLY SIRONA by 9.5% in the first quarter. Penserra Capital Management LLC now owns 2,760 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 240 shares during the period. Howland Capital Management LLC purchased a new position in shares of DENTSPLY SIRONA during the first quarter valued at approximately $203,000. Focused Wealth Management Inc increased its position in shares of DENTSPLY SIRONA by 179.2% in the fourth quarter. Focused Wealth Management Inc now owns 4,051 shares of the medical instruments supplier’s stock valued at $234,000 after buying an additional 2,600 shares during the period. Finally, Private Advisor Group LLC purchased a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at approximately $247,000. 95.29% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Shares of DENTSPLY SIRONA Inc. (NASDAQ XRAY) traded up 0.62% during trading on Friday, hitting $63.70. 1,700,481 shares of the company traded hands. The company has a 50 day moving average price of $63.20 and a 200 day moving average price of $61.05. The company has a market capitalization of $14.60 billion, a price-to-earnings ratio of 40.99 and a beta of 1.25. DENTSPLY SIRONA Inc. has a 52 week low of $55.00 and a 52 week high of $65.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Tuesday, May 9th. The medical instruments supplier reported $0.49 EPS for the quarter, missing the consensus estimate of $0.50 by $0.01. DENTSPLY SIRONA had a net margin of 9.42% and a return on equity of 7.37%. The business had revenue of $900.50 million during the quarter, compared to the consensus estimate of $916.55 million. During the same quarter in the prior year, the firm posted $0.69 EPS. The company’s revenue for the quarter was up 16.6% compared to the same quarter last year. On average, analysts expect that DENTSPLY SIRONA Inc. will post $2.84 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “DENTSPLY SIRONA Inc. (XRAY) Position Decreased by Rothschild Asset Management Inc.” was originally reported by Watch List News and is owned by of Watch List News. If you are reading this report on another domain, it was stolen and republished in violation of U.S. and international copyright & trademark law. The original version of this report can be accessed at https://www.watchlistnews.com/dentsply-sirona-inc-xray-position-decreased-by-rothschild-asset-management-inc/1372518.html.

Several equities analysts have recently commented on XRAY shares. Cleveland Research raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 23rd. BidaskClub downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday, June 10th. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating and set a $71.00 price objective for the company in a research note on Tuesday, May 2nd. Barrington Research downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Tuesday, February 21st. Finally, Goldman Sachs Group, Inc. (The) downgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and lowered their price objective for the company from $60.00 to $55.00 in a research note on Tuesday, May 23rd. One analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $66.44.

In other news, CEO Christopher T. Clark sold 89,700 shares of the business’s stock in a transaction dated Friday, April 7th. The shares were sold at an average price of $62.67, for a total value of $5,621,499.00. Following the completion of the sale, the chief executive officer now owns 112,067 shares in the company, valued at approximately $7,023,238.89. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO James G. Mosch sold 50,600 shares of the business’s stock in a transaction dated Monday, April 24th. The shares were sold at an average price of $63.49, for a total transaction of $3,212,594.00. Following the completion of the sale, the chief executive officer now owns 105,083 shares of the company’s stock, valued at approximately $6,671,719.67. The disclosure for this sale can be found here. Insiders own 1.99% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.